GIBAX | PDBZX | GIBAX / PDBZX | |
Total Expense Ratio | 0.84 | 0.49 | 171% |
Annual Report Gross Expense Ratio | 0.88 | 0.50 | 176% |
Fund Existence | 14 years | 29 years | - |
Gain YTD | 6.568 | 6.373 | 103% |
Front Load | 4% | N/A | - |
Min. Initial Investment | 2500 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 29.2B | 51.2B | 57% |
Annual Yield % from dividends | 4.67 | 4.60 | 102% |
Returns for 1 year | 4.31 | 3.91 | 110% |
Returns for 3 years | 15.01 | 14.83 | 101% |
Returns for 5 years | -1.76 | -0.05 | 3,233% |
Returns for 10 years | 27.91 | 23.70 | 118% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
HELX | 30.62 | 0.36 | +1.20% |
Franklin Genomic Advancements ETF | |||
PHYL | 35.62 | 0.07 | +0.21% |
PGIM Active High Yield Bond ETF | |||
ADX | 21.77 | 0.02 | +0.09% |
Adams Diversified Equity Fund | |||
PYT | 23.03 | N/A | N/A |
Merrill Lynch Depositor PPLUS Floating Rate Call TR Cert Ser GSC-2(Goldman Sachs) | |||
FVC | 36.10 | -0.03 | -0.10% |
First Trust Dorsey Wright Dynamic Foc 5 |